Human ctDNA Comprehensive Cancer Gene Mutation Test Kit
Genecast ctDNA Comprehensive is a DNA-based NGS assay designed to comprehensively and accurately assess the mutation profiles, mutational burden, microsatellite instability (MSI) in blood. The 769 genes related to tumor occurrence and development are detected, of which 370 genes highly related to clinical diagnosis, treatment orprognosis are fully covered in the whole exon coding region, and the other 399 genes are covering common variant hotspots SNP regions relevant to drug metabolism, and microsatellite regions.
Genecast ctDNA Comprehensive provides information of molecular typing, guidance on targeted, immunotherapeutic, and chemotherapeutic drugs, drug resistance insights.
Key Features and Benefits
Comprehensive Coverage
Comprehensively covers the biomarkers for tumor targeted therapy, immunotherapy, chemotherapy
Superb Performance
Detects all the variant types including SNVs, Indels, CNVs, Fusions, Skippings, SNPs, TMB, and MSI
Employs a unique CNV algorithm to effectively differentiate copy number variations from polyploid
Comprehensive Multidimensional Assessment of Immuno-Oncology (IO) Markers
Multidimensional assessment of TMB, MSI and IO genes
Specifications